1 citations
,
March 2021 in “Skin health and disease” This review evaluates laboratory models used in androgenetic alopecia research but reports no new findings, emphasizing the potential of human-derived 3-D models for future studies.
1 citations
,
September 2020 in “Cochrane library (CD-ROM)” This Cochrane Review protocol aims to evaluate the effectiveness and safety of various treatments for alopecia areata through a network meta-analysis, but no specific study findings are reported yet.
1 citations
,
October 2019 in “Proceedings Mulawarman Pharmaceuticals Conference” This study observed that aloe vera serum was comparable to minoxidil in promoting hair growth over 21 days but had no effect on sun protection.
1 citations
,
May 2017 in “InTech eBooks” This review addresses alopecia areata, emphasizing its autoimmune nature, unpredictable course, and lack of preventive or curative treatments, while noting standard and emerging therapies such as topical steroids and Janus kinase inhibitors.
1 citations
,
January 2017 in “Springer eBooks” This review discusses recent advances in understanding alopecia areata's disease mechanisms and highlights JAK molecules as promising therapeutic targets, but reports no new clinical results; controlled trials are needed.
1 citations
,
April 2016 in “CRC Press eBooks” Skin aging reflects overall body aging and can indicate internal health conditions.
1 citations
,
May 2010 in “Nursing Standard” Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.
1 citations
,
April 2009 in “Cochrane Database of Systematic Reviews” This protocol outlines a planned Cochrane Review assessing the effectiveness and safety of treatments for androgenic alopecia in women, reporting no new research findings.
1 citations
,
January 2009 in “Cochrane Database of Systematic Reviews” This protocol outlines a planned Cochrane Review to evaluate the effectiveness and safety of treatment options for androgenic alopecia in women, without reporting new findings yet.
April 2026 in “Scientific Reports” In this study, the proposed MSF-VMDNet, combining dual encoder networks with a multi-frequency domain mechanism, significantly outperformed existing methods in segmenting skin cancer tissues from histological slide images, achieving high accuracy with an MIoU of 95.37% and a Dice coefficient of 95.11%.
January 2026 in “Frontiers in Pharmacology” This review highlights the potential of wedelolactone from the plant Wedelia Chinensis, summarizing its reported pharmacological effects, including anti-inflammatory, antiviral, antibacterial, antitumor, anti-osteoporosis activities, and organ protection based on existing in vitro and in vivo research findings.
October 2025 in “Dermatology and Therapy” This study evaluates the efficacy and safety of a higher dose (100-mg) of ritlecitinib for treating severe alopecia areata, comparing it to external and synthetic placebo control groups.
This study discovered that in *Drosophila*, knockdown of specific storage proteins in adipocytes decreased germline stem cell maintenance, implicating a role for these proteins in adult tissue regulation.
This summary highlights key contents of the latest issue of the Austrian dermatology journal, SKIN, including coverage of the ÖADF conference program, introduction of a "Phlebology Certificate," and new SKINdeep open-access articles.
In this review, researchers evaluated 111 studies on the biological activities and phytochemical components of the plant Tridax procumbens, emphasizing its ethnobotanical potential and the need for more research to understand its therapeutic benefits, especially in its native tropical regions.
January 2025 in “Bright Sky Publications eBooks” This abstract serves as a promotional notice for a book titled "Essentials of Food Science and Nutrition" by several authors, offering it for sale at a low price, but does not report any research results.
March 2024 in “Journal of pharmacopuncture” In this study, a patient with stress-induced Alopecia areata treated eight times with Hominis Placenta Pharmacopunture showed new terminal hair growth and a reduced lesion size, suggesting potential effectiveness of this treatment for the condition.
March 2024 in “Dermatology and therapy” This study analyzed data from 2083 patients with alopecia areata in Europe and found that those with atopic, autoimmune, or psychiatric comorbidities encountered more severe disease and were more likely to require advanced treatments compared to those without comorbid conditions.
February 2024 in “Sohag Medical Journal” This review discusses the challenges in treating alopecia areata and the potential psychological impact, noting that spontaneous hair regrowth often occurs and highlighting the consideration of psychotherapy alongside treatment options; it reports no new experimental results.
January 2024 in “Journal of applied biological chemistry” This study found that Glehnia littoralis and Andrographis paniculata may support hair growth by protecting against oxidative stress and increasing VEGF and Wnt/β-catenin signaling in human hair follicle dermal papilla cells, with enhanced effects when combined.
January 2024 in “American journal of clinical dermatology” This study reports that ritlecitinib, when used for up to 24 months in patients aged 12 and older with alopecia areata, has an acceptable safety profile, with a similar proportion of adverse events in both ritlecitinib and placebo groups in the placebo-controlled cohort.
December 2023 in “EPRA international journal of multidisciplinary research” In this review, researchers examined current knowledge on alopecia areata, finding it affects approximately 2% of individuals, with a likely autoimmune and genetic basis, and highlighting its association with other medical and psychiatric conditions, although no cure currently exists.
October 2023 in “Cognizance journal” This study explores using agent-based modeling and nutrition science to predict and treat oral and dental diseases as alternatives to traditional incarceration for managing criminal behavior, but results are not reported.
October 2023 in “Plant Archives/Plant archives” This study evaluated herbal formulations, including Neem and Hibiscus soaps and medicated oil, made from certain medicinal plants in India, finding them effective for antimicrobial purposes and beneficial for skin and hair, suggesting they are suitable for public use.
July 2023 in “International journal of pharmacognosy and life science” This study explores the development of a herbal hair oil formulation using selected herbs to potentially address hair loss and related issues, as an alternative to synthetic medications that may cause serious side effects and offer limited effectiveness.
May 2023 in “Sučasna pedìatrìâ. Ukraïna” In a clinical observation study, researchers documented a case of total alopecia in an 11-year-old child, highlighting a potential link to genetic conditions such as autoimmune polyendocrinopathy candidiasis-ectodermal dystrophy (APECED syndrome) requiring further genetic and serological testing to verify the diagnosis.
January 2023 in “International journal of homoeopathic sciences” This article discusses homeopathic treatments for alopecia areata, asserting their effectiveness in promoting hair growth, but reports no new clinical findings.
September 2022 in “bioRxiv (Cold Spring Harbor Laboratory)” This study applied a new RGB trichrome stain to human skin samples, revealing distinct structural staining in normal tissues and potential proteoglycan-rich zones in hair follicles.
August 2022 in “International journal of research in pharmacy and chemistry” This review summarizes the chemical composition and pharmacological properties of Teak (Tectona grandis) but presents no new research findings, emphasizing its use in traditional medicine and therapeutic potentials.
June 2022 in “International Journal for Research in Applied Science and Engineering Technology” The research developed a herbal shampoo using extracts from Piper Betel and Psidium Guajava leaves, which showed potential in promoting hair growth and managing hair diseases, while replacing synthetic ingredients with safe natural alternatives.